Trial Condition(s):
BAY38-9456 MD Formulation selection 2 x 20 mg ER prototypes
Please see attached Study Results Summary below
No Inclusion Criteria Available
No Exclusion Criteria Available
Locations | Status | ||
---|---|---|---|
Locations Bayer HealthCare Wuppertal, Germany, 42096 | Status Completed | Contact Us: E-mail: [email protected] Phone: Not Available |